News Industry News New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation February 25, 2020
News Conference News ISC 2020 SKIP Questions Need for IV Thrombolysis Before Stroke Thrombectomy Todd Neale February 25, 2020
News Conference News ISC 2020 No Need to Go to Higher Tenecteplase Dose for Acute Stroke Todd Neale February 21, 2020
News Daily News BBC Makes New EXCEL Allegations, Says Investigators Ignored Safety Concerns Michael O'Riordan February 21, 2020
News Conference News ISC 2020 Another Neuroprotective Agent Fails in Acute Stroke . . . Or Does It? Todd Neale February 21, 2020
News Daily News Impella Redux: JAMA Publication Post-AHA Renews Push for More Data Caitlin E. Cox February 14, 2020
News Daily News Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion Yael L. Maxwell February 14, 2020
News Daily News Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis Michael O'Riordan February 10, 2020
News Daily News CCTA to Avoid Invasive Cath in NSTE ACS? Clues From VERDICT Shelley Wood February 03, 2020
News Daily News Formal Shared Decision-Making Aid for TAVR Gets Mixed Reviews Michael O'Riordan January 31, 2020
News Conference News ISET 2020 Venous Stents: Long-term Follow-up Plus a New Contender Caitlin E. Cox January 24, 2020
News Daily News MitraClip in the US: As Coverage Update Looms, Some Questions for REPAIR MR Shelley Wood January 24, 2020
News Daily News Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events Shelley Wood January 20, 2020
News Daily News Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL Michael O'Riordan January 17, 2020
News Daily News Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI L.A. McKeown January 15, 2020
News Daily News CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA Shelley Wood January 14, 2020
News Daily News Community Death Rates Following Type 2 MI Speak to Lack of Treatments, Trials Yael L. Maxwell January 10, 2020
News Features ‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry Michael O'Riordan January 10, 2020
News Daily News Diabetes Does Not Appear to Hinder FFR Insights for CAD Caitlin E. Cox January 09, 2020
News Daily News EACTS Offers to Help to Resolve EXCEL Controversy, as CRF Launches Review Michael O'Riordan January 08, 2020